| Current status and recent advances of liver transplantation from donation after cardiac death |
| |
Current status and recent advances of liver transplantation from donation after cardiac death
World J Gastrointest Surg 2011 November 27; 3(11): 167-176
M Thamara PR Perera, Simon R Bramhall
|
|
|
| Immunosuppressive therapy after human lung transplantation |
| |
Immunosuppressive therapy after human lung transplantation
Eur Respir J 2004; 23: 159–171
C. Knoop, A. Haverich, S. Fischer |
|
|
| Kidney Transplantation: The Ideal Immunosuppression Regimen |
| |
Kidney Transplantation: The Ideal Immunosuppression Regimen
Advances in Chronic Kidney Disease, Vol 16, No 4 (July), 226 2009: pp 226-233
Julie M. Yabu and Flavio Vincenti
|
|
|
| Past, present & future scenario of thalassaemic care & control in India |
| |
Past, present & future scenario of thalassaemic care & control in India
Indian J Med Res 134, October 2011, pp 507-521
Ishwar C. Verma, Renu Saxena & Sudha Kohli
|
|
|
| Oral Iron Chelators: A New Avenue for the Management of Thalassemia Major |
| |
Oral Iron Chelators: A New Avenue for the Management of Thalassemia Major
Journal of Current Pharmaceutical Research 2010; 01: 1-7
Ritesh N. Sharma and S. S. Pancholi
|
|
|
| Chronic kidney disease |
| |
Chronic kidney disease
Lancet 2012; 379: 165–80
Andrew S Levey, Josef Coresh
|
|
|
| The case for wider use of recombinant factor VIII concentrates |
| |
The case for wider use of recombinant factor VIII concentrates
Critical reviews in oncology/ hematology
Cedric Hermansa, Hans-Hermann Brackmann, Piercarla Schinco , Günter Auerswald
|
|
|
| Combined chelation therapy with deferasirox and deferoxamine in thalassemia |
| |
Combined chelation therapy with deferasirox and deferoxamine in thalassemia
Blood Cells, Molecules and Diseases 50 (2013) 99–104
Ashutosh Lal, John Porter, Nancy Sweeters , Vivian Ng , Patricia Evans , Lynne Neumayr ,Gregory Kurio , Paul Harmatz , Elliott Vichinsky
|
|
|